Comment on "A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout".

Rheumatol Ther

Department of General Practice, Erasmus Medical Center, Rotterdam, The Netherlands.

Published: March 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021887	PMC
http://dx.doi.org/10.1007/s40744-019-00187-2	DOI Listing

Publication Analysis

comment randomized

randomized double-blind

double-blind non-inferiority

non-inferiority study

study febuxostat

febuxostat versus

versus allopurinol

allopurinol hyperuricemic

hyperuricemic chinese

chinese subjects

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!